(NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 15.38%, which has investors questioning if this is right time to buy.

While the most well-known and successful applications of 'cell-free' technologies ... diagnostics utilizing cell-free DNA/RNA (cfDNA/RNA), cell-free protein synthesis (CFPS, among others), these ...

While the most well-known and successful applications of ‘cell ... free’ technologies include next-generation sequencing-based diagnostics utilizing cell-free DNA/RNA (cfDNA/RNA), cell-free ...

A previous study from Burd's lab found that protein intakes higher than 1.1 g/kg per day make no difference to the rate of muscle protein synthesis when weight training.

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper The authors intend the ...

The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free ... utilizing cell-free DNA/RNA (cfDNA/RNA), cell-free protein synthesis (CFPS ...

The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufacturing—a biomanufacturing method to produce chemicals without relying on living ...